What are the side effects of fostemsavir?

Fostemsavir is a new antiviral drug used to treat infection with human immunodeficiency virus type 1 (HIV-1). It is mainly used to treat adult patients who are resistant to existing antiviral treatments. HIV-1 is a virus that causes acquired immunodeficiency syndrome (AIDS), posing a serious threat to patients' health. Folstansavir is often used in combination with other anti-HIV drugs to enhance the effectiveness of treatment, especially in the setting of multidrug-resistant HIV-1.

In clinical studies, the side effects of fostansavir are relatively common, and the occurrence of these adverse reactions may affect patients' medication compliance. The most common adverse reactions include nausea, diarrhea, headache, and abdominal pain. These digestive system-related discomforts may affect the patient's daily life and therefore require appropriate management and adjustments by a physician. In addition, indigestion and fatigue were reported as common adverse effects, suggesting that the drug may have a negative impact on the patient's overall health status.

In addition, side effects such as rash, sleep disturbance, drowsiness and vomiting are also worth noting. The appearance of a rash may indicate an allergic reaction or drug intolerance, so patients should seek medical attention promptly if they experience such symptoms. Sleep disorders and somnolence may affect the patient's mental state and quality of life, and need to be treated accordingly according to individual circumstances.

Of all adverse reactions, the most serious may be immune reconstitution inflammatory syndrome (IRIS). This condition typically occurs as a patient's immune system begins to recover, possibly due to the immune system overreacting to a pre-existing underlying infection, causing inflammation and damage to healthy tissue. Therefore, when initiating treatment with fostansavir, physicians should fully assess the patient's immune status and monitor accordingly to prevent potential risks from IRIS.

It is worth mentioning that the use of fostansavir is limited by some drug interactions. In particular, it should not be taken with certain drugs known as "strong CYP3A inducers," such as the epilepsy drugs carbamazepine and phenytoin, the cancer drugs mitotane and enzalutamide, the antibiotic drug rifampicin, and the herb St. John's wort. These drugs may reduce the efficacy of fostansavir, thereby affecting the effectiveness of the entire antiviral treatment.

Reference materials:https://clinicalinfo.hiv.gov/en/drugs/fostemsavir/patient